{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T09:37:40Z","timestamp":1793957860165,"version":"4.8.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["215519\/Z\/19\/Z"],"award-info":[{"award-number":["215519\/Z\/19\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["219531\/Z\/19\/Z"],"award-info":[{"award-number":["219531\/Z\/19\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["219531\/Z\/19\/Z"],"award-info":[{"award-number":["219531\/Z\/19\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"RCUK | Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/Z517215\/1"],"award-info":[{"award-number":["BB\/Z517215\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"RCUK | Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/Z517215\/1"],"award-info":[{"award-number":["BB\/Z517215\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K15295"],"award-info":[{"award-number":["22K15295"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K09819"],"award-info":[{"award-number":["24K09819"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"RCUK | Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["EP\/X035603\/1"],"award-info":[{"award-number":["EP\/X035603\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"RCUK | Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["EP\/X035603\/1"],"award-info":[{"award-number":["EP\/X035603\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Organic anion-transporting polypeptide transporters (SLCO\/OATPs) function as cellular gatekeepers, regulating intestinal absorption, hepatic and renal clearance, and the tissue distribution of drugs and metabolites in the human body. However, the mechanisms underlying substrate selection within the SLCO superfamily remain unclear, hampering efforts to rationalize the interaction of drugs and metabolites with these transporters. SLCO2A1 (also known as OATP2A1) is responsible for the distribution of eicosanoids, including prostaglandins (PGs) and thromboxanes, throughout the body, in addition to several families of nonsteroidal anti-inflammatory drugs (NSAIDs). Here, we present cryogenic electron microscopy structures of SLCO2A1 bound to endogenous PGs and to four widely prescribed medications for treating inflammation, chronic asthma, and Parkinson\u2019s disease (PD). Complementary molecular dynamics and in vivo cellular assays elucidate the molecular basis for PG and drug recognition. Our study reports essential mechanistic details that underpin substrate selection and subfamily adaptation within the broader SLCO superfamily of drug and metabolite transporters.<\/jats:p>","DOI":"10.1038\/s41467-026-70227-3","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T10:02:03Z","timestamp":1774000923000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Structural basis for prostaglandin and drug transport via SLCO2A1"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0045-964X","authenticated-orcid":false,"given":"Chitra","family":"Joshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8811-9871","authenticated-orcid":false,"given":"Justin C.","family":"Deme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3658-1663","authenticated-orcid":false,"given":"Yoshinobu","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Tse","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Goult","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2964-2720","authenticated-orcid":false,"given":"Joanne L.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5100-8836","authenticated-orcid":false,"given":"Philip C.","family":"Biggin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9287-8053","authenticated-orcid":false,"given":"Susan M.","family":"Lea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6561-7138","authenticated-orcid":false,"given":"Takeo","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7432-2270","authenticated-orcid":false,"given":"Simon","family":"Newstead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"key":"70227_CR1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41573-023-00877-1","volume":"23","author":"A Galetin","year":"2024","unstructured":"Galetin, A. et al. Membrane transporters in drug development and as determinants of precision medicine. Nat. Rev. Drug Discov. 23, 255\u2013280 (2024).","journal-title":"Nat. Rev. Drug Discov."},{"key":"70227_CR2","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nrd4626","volume":"14","author":"L Lin","year":"2015","unstructured":"Lin, L., Yee, S. W., Kim, R. B. & Giacomini, K. M. SLC transporters as therapeutic targets: emerging opportunities. Nat. Rev. Drug Discov. 14, 543\u2013560 (2015).","journal-title":"Nat. Rev. Drug Discov."},{"key":"70227_CR3","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nrd3028","volume":"9","author":"KM Giacomini","year":"2010","unstructured":"Giacomini, K. M. et al. Membrane transporters in drug development. Nat. Rev. Drug Discov. 9, 215\u2013236 (2010).","journal-title":"Nat. Rev. Drug Discov."},{"key":"70227_CR4","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.cell.2015.07.022","volume":"162","author":"A Cesar-Razquin","year":"2015","unstructured":"Cesar-Razquin, A. et al. A call for systematic research on solute carriers. Cell 162, 478\u2013487 (2015).","journal-title":"Cell"},{"key":"70227_CR5","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.mam.2012.10.009","volume":"34","author":"B Hagenbuch","year":"2013","unstructured":"Hagenbuch, B. & Stieger, B. The SLCO (former SLC21) superfamily of transporters. Mol. Asp. Med. 34, 396\u2013412 (2013).","journal-title":"Mol. Asp. Med."},{"key":"70227_CR6","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1007\/s00424-003-1089-9","volume":"447","author":"H Koepsell","year":"2004","unstructured":"Koepsell, H. & Endou, H. The SLC22 drug transporter family. Pflgers Arch. Eur. J. Physiol. 447, 666\u2013676 (2004).","journal-title":"Pflgers Arch. Eur. J. Physiol."},{"key":"70227_CR7","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.tibs.2023.05.011","volume":"48","author":"A Schlessinger","year":"2023","unstructured":"Schlessinger, A., Zatorski, N., Hutchinson, K. & Colas, C. Targeting SLC transporters: small molecules as modulators and therapeutic opportunities. Trends Biochem. Sci. 48, 801\u2013814 (2023).","journal-title":"Trends Biochem. Sci."},{"key":"70227_CR8","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s00424-003-1168-y","volume":"447","author":"B Hagenbuch","year":"2004","unstructured":"Hagenbuch, B. & Meier, P. J. Organic anion transporting polypeptides of the OATP\/ SLC21 family: phylogenetic classification as OATP\/ SLCO superfamily, new nomenclature and molecular\/functional properties. Pflug. Arch. 447, 653\u2013665 (2004).","journal-title":"Pflug. Arch."},{"key":"70227_CR9","doi-asserted-by":"publisher","first-page":"107803","DOI":"10.1016\/j.pharmthera.2021.107803","volume":"223","author":"T Nakanishi","year":"2021","unstructured":"Nakanishi, T., Nakamura, Y. & Umeno, J. Recent advances in studies of SLCO2A1 as a key regulator of the delivery of prostaglandins to their sites of action. Pharm. Ther. 223, 107803 (2021).","journal-title":"Pharm. Ther."},{"key":"70227_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1208\/s12248-017-0163-8","volume":"20","author":"T Nakanishi","year":"2017","unstructured":"Nakanishi, T. & Tamai, I. Roles of organic anion transporting polypeptide 2A1 (OATP2A1\/SLCO2A1) in regulating the pathophysiological actions of prostaglandins. AAPS J. 20, 13 (2017).","journal-title":"AAPS J."},{"key":"70227_CR11","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.tips.2012.02.004","volume":"33","author":"T Aoki","year":"2012","unstructured":"Aoki, T. & Narumiya, S. Prostaglandins and chronic inflammation. Trends Pharm. Sci. 33, 304\u2013311 (2012).","journal-title":"Trends Pharm. Sci."},{"key":"70227_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2024.110298","volume":"265","author":"M Luo","year":"2024","unstructured":"Luo, M. et al. Roles of prostaglandins in immunosuppression. Clin. Immunol. 265, 110298 (2024).","journal-title":"Clin. Immunol."},{"key":"70227_CR13","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1172\/JCI6749","volume":"107","author":"JL Stock","year":"2001","unstructured":"Stock, J. L. et al. The prostaglandin E2 EP1 receptor mediates pain perception and regulates blood pressure. J. Clin. Investig. 107, 325\u2013331 (2001).","journal-title":"J. Clin. Investig."},{"key":"70227_CR14","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0079-6123(08)62033-6","volume":"115","author":"AS Milton","year":"1998","unstructured":"Milton, A. S. Prostaglandins and fever. Prog. Brain Res. 115, 129\u2013139 (1998).","journal-title":"Prog. Brain Res."},{"key":"70227_CR15","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev.pharmtox.011008.145616","volume":"49","author":"T Shimizu","year":"2009","unstructured":"Shimizu, T. Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation. Annu. Rev. Pharm. Toxicol. 49, 123\u2013150 (2009).","journal-title":"Annu. Rev. Pharm. Toxicol."},{"key":"70227_CR16","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00404-017-4418-5","volume":"296","author":"R Bakker","year":"2017","unstructured":"Bakker, R., Pierce, S. & Myers, D. The role of prostaglandins E1 and E2, dinoprostone, and misoprostol in cervical ripening and the induction of labor: a mechanistic approach. Arch. Gynecol. Obstet. 296, 167\u2013179 (2017).","journal-title":"Arch. Gynecol. Obstet."},{"key":"70227_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s11658-025-00685-y","volume":"30","author":"M Biernacki","year":"2025","unstructured":"Biernacki, M. & Skrzydlewska, E. Metabolic pathways of eicosanoids-derivatives of arachidonic acid and their significance in skin. Cell Mol. Biol. Lett. 30, 7 (2025).","journal-title":"Cell Mol. Biol. Lett."},{"key":"70227_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1536\/ihj.24-615","volume":"66","author":"T Fujiwara","year":"2025","unstructured":"Fujiwara, T., Ishii, S., Minatsuki, S., Hatano, M. & Takeda, N. Exploring novel therapeutics for pulmonary arterial hypertension. Int Heart J. 66, 3\u201312 (2025).","journal-title":"Int Heart J."},{"key":"70227_CR19","unstructured":"Harwood, J. L. et al. Lipids: Biology and Health, 6th edn. edn 1 online resource (John Wiley & Sons Inc., 2016)."},{"key":"70227_CR20","doi-asserted-by":"publisher","first-page":"6209","DOI":"10.1021\/cr200010h","volume":"111","author":"T Hirata","year":"2011","unstructured":"Hirata, T. & Narumiya, S. Prostanoid receptors. Chem. Rev. 111, 6209\u20136230 (2011).","journal-title":"Chem. Rev."},{"key":"70227_CR21","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1124\/mol.65.4.973","volume":"65","author":"T Nomura","year":"2004","unstructured":"Nomura, T., Lu, R., Pucci, M. L. & Schuster, V. L. The two-step model of prostaglandin signal termination: in vitro reconstitution with the prostaglandin transporter and prostaglandin 15 dehydrogenase. Mol. Pharm. 65, 973\u2013978 (2004).","journal-title":"Mol. Pharm."},{"key":"70227_CR22","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1126\/science.7754369","volume":"268","author":"N Kanai","year":"1995","unstructured":"Kanai, N. et al. Identification and characterization of a prostaglandin transporter. Science 268, 866\u2013869 (1995).","journal-title":"Science"},{"key":"70227_CR23","doi-asserted-by":"publisher","first-page":"100452","DOI":"10.1016\/j.dmpk.2022.100452","volume":"44","author":"Y Nakamura","year":"2022","unstructured":"Nakamura, Y., Kozakai, H., Nishio, T., Yoshida, K. & Nakanishi, T. Phenolsulfonphthalein as a surrogate substrate to assess altered function of the prostaglandin transporter SLCO2A1. Drug Metab. Pharmacokinet. 44, 100452 (2022).","journal-title":"Drug Metab. Pharmacokinet."},{"key":"70227_CR24","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1056\/NEJMicm2113457","volume":"386","author":"N Yadav","year":"2022","unstructured":"Yadav, N. & Yanamandra, U. Primary hypertrophic osteoarthropathy. N. Engl. J. Med. 386, e22 (2022).","journal-title":"N. Engl. J. Med."},{"key":"70227_CR25","doi-asserted-by":"publisher","first-page":"e1005581","DOI":"10.1371\/journal.pgen.1005581","volume":"11","author":"J Umeno","year":"2015","unstructured":"Umeno, J. et al. A hereditary enteropathy caused by mutations in the SLCO2A1 gene, encoding a prostaglandin transporter. PLoS Genet. 11, e1005581 (2015).","journal-title":"PLoS Genet."},{"key":"70227_CR26","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.3748\/wjg.v30.i19.2505","volume":"30","author":"ZX Xie","year":"2024","unstructured":"Xie, Z. X., Li, Y., Yang, A. M., Wu, D. & Wang, Q. Pathogenesis of chronic enteropathy associated with the SLCO2A1 gene: hypotheses and conundrums. World J. Gastroenterol. 30, 2505\u20132511 (2024).","journal-title":"World J. Gastroenterol."},{"key":"70227_CR27","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.ajpath.2012.03.012","volume":"181","author":"MM Syeda","year":"2012","unstructured":"Syeda, M. M. et al. Prostaglandin transporter modulates wound healing in diabetes by regulating prostaglandin-induced angiogenesis. Am. J. Pathol. 181, 334\u2013346 (2012).","journal-title":"Am. J. Pathol."},{"key":"70227_CR28","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1146\/annurev-biochem-060815-014520","volume":"85","author":"D Drew","year":"2016","unstructured":"Drew, D. & Boudker, O. Shared molecular mechanisms of membrane transporters. Annu. Rev. Biochem 85, 543\u2013572 (2016).","journal-title":"Annu. Rev. Biochem"},{"key":"70227_CR29","doi-asserted-by":"crossref","unstructured":"Vichara-Anont, I., Lumkul, L., Phinyo, P., Wongsa, C. & Thongngarm, T. Efficacy and safety of maintenance regimens for adolescent and adult asthmatics with exercise-induced bronchospasm: Systematic review and network meta-analysis. J. Allergy Clin. Immunol. Pract. (2025).","DOI":"10.1016\/j.jaip.2025.02.018"},{"key":"70227_CR30","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1021\/jm00257a010","volume":"17","author":"K Brown","year":"1974","unstructured":"Brown, K. et al. Nonsteroidal antiinflammatory agents. 1.2,4-Diphenylthiazole-5-acetic acid and related compounds. J. Med Chem. 17, 1177\u20131181 (1974).","journal-title":"J. Med Chem."},{"key":"70227_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/NDT.S2404","volume":"4","author":"A Antonini","year":"2008","unstructured":"Antonini, A. et al. COMT inhibition with tolcapone in the treatment algorithm of patients with Parkinson\u2019s disease (PD): relevance for motor and non-motor features. Neuropsychiatr. Dis. Treat. 4, 1\u20139 (2008).","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"70227_CR32","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1124\/mol.118.114314","volume":"95","author":"RR Schulte","year":"2019","unstructured":"Schulte, R. R. & Ho, R. H. Organic anion transporting polypeptides: emerging roles in cancer pharmacology. Mol. Pharm. 95, 490\u2013506 (2019).","journal-title":"Mol. Pharm."},{"key":"70227_CR33","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1016\/j.xphs.2017.04.046","volume":"106","author":"S Kamo","year":"2017","unstructured":"Kamo, S. et al. Impact of FDA-approved drugs on the prostaglandin transporter OATP2A1\/SLCO2A1. J. Pharm. Sci. 106, 2483\u20132490 (2017).","journal-title":"J. Pharm. Sci."},{"key":"70227_CR34","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ads5405","volume":"11","author":"X Wu","year":"2025","unstructured":"Wu, X. et al. Structures and membrane interactions of human OAT1 in complex with clinical used drugs. Sci. Adv. 11, eads5405 (2025).","journal-title":"Sci. Adv."},{"key":"70227_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56843-5","volume":"16","author":"W Guo","year":"2025","unstructured":"Guo, W. et al. Mechanisms of urate transport and uricosuric drugs inhibition in human URAT1. Nat. Commun. 16, 1512 (2025).","journal-title":"Nat. Commun."},{"key":"70227_CR36","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s41422-024-01023-1","volume":"34","author":"Y Dai","year":"2024","unstructured":"Dai, Y. & Lee, C. H. Transport mechanism and structural pharmacology of human urate transporter URAT1. Cell Res 34, 776\u2013787 (2024).","journal-title":"Cell Res"},{"key":"70227_CR37","doi-asserted-by":"crossref","unstructured":"Parker, J. L., Kato, T., Kuteyi, G., Sitsel, O. & Newstead, S. Molecular basis for selective uptake and elimination of organic anions in the kidney by OAT1. Nat. Struct. Mol. Biol. (2023).","DOI":"10.1038\/s41594-023-01039-y"},{"key":"70227_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41552-8","volume":"14","author":"AD Ciuta","year":"2023","unstructured":"Ciuta, A. D. et al. Structure of human drug transporters OATP1B1 and OATP1B3. Nat. Commun. 14, 5774 (2023).","journal-title":"Nat. Commun."},{"key":"70227_CR39","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/s41422-023-00870-8","volume":"33","author":"Z Shan","year":"2023","unstructured":"Shan, Z. et al. Cryo-EM structures of human organic anion transporting polypeptide OATP1B1. Cell Res 33, 940\u2013951 (2023).","journal-title":"Cell Res"},{"key":"70227_CR40","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1038\/s42003-025-08510-0","volume":"8","author":"P Yu","year":"2025","unstructured":"Yu, P., Orlando, M. A. & Orlando, B. J. Structure and post-translational modification of the prostaglandin transporter. Commun. Biol. 8, 1066 (2025).","journal-title":"Commun. Biol."},{"key":"70227_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-63615-8","volume":"16","author":"Z Xia","year":"2025","unstructured":"Xia, Z. et al. Structure and transport mechanism of the human prostaglandin transporter SLCO2A1. Nat. Commun. 16, 8124 (2025).","journal-title":"Nat. Commun."},{"key":"70227_CR42","doi-asserted-by":"crossref","unstructured":"Zhu, Z. et al. Molecular basis of prostaglandin E(2) reuptake by organic anion transporter PGT. Nat. Commun. (2025).","DOI":"10.1038\/s41467-025-67025-8"},{"key":"70227_CR43","doi-asserted-by":"publisher","first-page":"106714","DOI":"10.1016\/j.prostaglandins.2023.106714","volume":"165","author":"Y Nakamura","year":"2023","unstructured":"Nakamura, Y., Aizawa, C., Kawata, H. & Nakanishi, T. N-glycosylation modifies prostaglandin E(2) uptake by reducing cell surface expression of SLCO2A1. Prostaglandins Other Lipid Mediat. 165, 106714 (2023).","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"70227_CR44","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.str.2014.12.012","volume":"23","author":"PW Fowler","year":"2015","unstructured":"Fowler, P. W. et al. Gating topology of the proton-coupled oligopeptide symporters. Structure 23, 290\u2013301 (2015).","journal-title":"Structure"},{"key":"70227_CR45","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1172\/JCI118897","volume":"98","author":"R Lu","year":"1996","unstructured":"Lu, R., Kanai, N., Bao, Y. & Schuster, V. L. Cloning, in vitro expression, and tissue distribution of a human prostaglandin transporter cDNA(hPGT). J. Clin. Investi. 98, 1142\u20131149 (1996).","journal-title":"J. Clin. Investi."},{"key":"70227_CR46","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.prostaglandins.2015.12.003","volume":"122","author":"T Gose","year":"2016","unstructured":"Gose, T. et al. Prostaglandin transporter (OATP2A1\/SLCO2A1) contributes to local disposition of eicosapentaenoic acid-derived PGE3. Prostaglandins Other Lipid Mediat 122, 10\u201317 (2016).","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"70227_CR47","first-page":"R734","volume":"277","author":"ML Pucci","year":"1999","unstructured":"Pucci, M. L. et al. Cloning of mouse prostaglandin transporter PGT cDNA: species-specific substrate affinities. Am. J. Physiol. 277, R734\u2013R741 (1999).","journal-title":"Am. J. Physiol."},{"key":"70227_CR48","doi-asserted-by":"publisher","first-page":"9215","DOI":"10.1021\/bi0203031","volume":"41","author":"BS Chan","year":"2002","unstructured":"Chan, B. S., Bao, Y. & Schuster, V. L. Role of conserved transmembrane cationic amino acids in the prostaglandin transporter PGT. Biochemistry 41, 9215\u20139221 (2002).","journal-title":"Biochemistry"},{"key":"70227_CR49","doi-asserted-by":"publisher","first-page":"25564","DOI":"10.1074\/jbc.274.36.25564","volume":"274","author":"BS Chan","year":"1999","unstructured":"Chan, B. S., Satriano, J. A. & Schuster, V. L. Mapping the substrate binding site of the prostaglandin transporter PGT by cysteine scanning mutagenesis. J. Biol. Chem. 274, 25564\u201325570 (1999).","journal-title":"J. Biol. Chem."},{"key":"70227_CR50","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/S0026-895X(25)09373-3","volume":"50","author":"S Itoh","year":"1996","unstructured":"Itoh, S. et al. Structural determinants of substrates for the prostaglandin transporter PGT. Mol. Pharm. 50, 738\u2013742 (1996).","journal-title":"Mol. Pharm."},{"key":"70227_CR51","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1002\/humu.22111","volume":"33","author":"CP Diggle","year":"2012","unstructured":"Diggle, C. P. et al. Prostaglandin transporter mutations cause pachydermoperiostosis with myelofibrosis. Hum. Mutat. 33, 1175\u20131181 (2012).","journal-title":"Hum. Mutat."},{"key":"70227_CR52","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1080\/09687680701496507","volume":"24","author":"MJ Lemieux","year":"2007","unstructured":"Lemieux, M. J. Eukaryotic major facilitator superfamily transporter modeling based on the prokaryotic GlpT crystal structure. Mol. Membr. Biol. 24, 333\u2013341 (2007).","journal-title":"Mol. Membr. Biol."},{"key":"70227_CR53","doi-asserted-by":"publisher","first-page":"5289","DOI":"10.1021\/acs.chemrev.0c00983","volume":"121","author":"D Drew","year":"2021","unstructured":"Drew, D., North, R. A., Nagarathinam, K. & Tanabe, M. Structures and general transport mechanisms by the major facilitator superfamily (MFS). Chem. Rev. 121, 5289\u20135335 (2021).","journal-title":"Chem. Rev."},{"key":"70227_CR54","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583\u2013589 (2021).","journal-title":"Nature"},{"key":"70227_CR55","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1146\/annurev.physiol.60.1.221","volume":"60","author":"VL Schuster","year":"1998","unstructured":"Schuster, V. L. Molecular mechanisms of prostaglandin transport. Annu. Rev. Physiol. 60, 221\u2013242 (1998).","journal-title":"Annu. Rev. Physiol."},{"key":"70227_CR56","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1007\/s11095-021-03107-8","volume":"38","author":"W Kiander","year":"2021","unstructured":"Kiander, W. et al. The effect of single nucleotide variations in the transmembrane domain of OATP1B1 on in vitro functionality. Pharm. Res. 38, 1663\u20131675 (2021).","journal-title":"Pharm. Res."},{"key":"70227_CR57","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1111\/j.1476-5381.2009.00568.x","volume":"159","author":"H Glaeser","year":"2010","unstructured":"Glaeser, H., Mandery, K., Sticht, H., Fromm, M. F. & Konig, J. Relevance of conserved lysine and arginine residues in transmembrane helices for the transport activity of organic anion transporting polypeptide 1B3. Br. J. Pharm. 159, 698\u2013708 (2010).","journal-title":"Br. J. Pharm."},{"key":"70227_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34284-8","volume":"13","author":"B Khanppnavar","year":"2022","unstructured":"Khanppnavar, B. et al. Structural basis of organic cation transporter-3 inhibition. Nat. Commun. 13, 6714 (2022).","journal-title":"Nat. Commun."},{"key":"70227_CR59","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1146\/annurev-pharmtox-030322-084058","volume":"63","author":"SK Nigam","year":"2023","unstructured":"Nigam, S. K. & Granados, J. C. OAT, OATP, and MRP drug transporters and the remote sensing and signaling theory. Annu. Rev. Pharm. Toxicol. 63, 637\u2013660 (2023).","journal-title":"Annu. Rev. Pharm. Toxicol."},{"key":"70227_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0005-2736(02)00633-8","volume":"1609","author":"B Hagenbuch","year":"2003","unstructured":"Hagenbuch, B. & Meier, P. J. The superfamily of organic anion transporting polypeptides. Biochim Biophys. Acta 1609, 1\u201318 (2003).","journal-title":"Biochim Biophys. Acta"},{"key":"70227_CR61","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1038\/s41596-018-0075-9","volume":"13","author":"J Elegheert","year":"2018","unstructured":"Elegheert, J. et al. Lentiviral transduction of mammalian cells for fast, scalable and high-level production of soluble and membrane proteins. Nat. Protoc. 13, 2991\u20133017 (2018).","journal-title":"Nat. Protoc."},{"key":"70227_CR62","doi-asserted-by":"crossref","unstructured":"Parker, J. L. et al. Cryo-EM structure of PepT2 reveals structural basis for proton-coupled peptide and prodrug transport in mammals. Sci. Adv. 7(2021).","DOI":"10.1126\/sciadv.abh3355"},{"key":"70227_CR63","volume":"4","author":"J Caesar","year":"2020","unstructured":"Caesar, J. et al. SIMPLE 3.0. Stream single-particle cryo-EM analysis in real time. J. Struct. Biol. X 4, 100040 (2020).","journal-title":"J. Struct. Biol. X"},{"key":"70227_CR64","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/s41592-020-00990-8","volume":"17","author":"A Punjani","year":"2020","unstructured":"Punjani, A., Zhang, H. & Fleet, D. J. Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction. Nat. Methods 17, 1214\u20131221 (2020).","journal-title":"Nat. Methods"},{"key":"70227_CR65","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1107\/S205225251801463X","volume":"6","author":"J Zivanov","year":"2019","unstructured":"Zivanov, J., Nakane, T. & Scheres, S. H. W. A Bayesian approach to beam-induced motion correction in cryo-EM single-particle analysis. IUCrJ 6, 5\u201317 (2019).","journal-title":"IUCrJ"},{"key":"70227_CR66","unstructured":"Asarnow, D., Palovcak, E. & Cheng, Y. UCSF pyem v0 Zenodo. (2019)."},{"key":"70227_CR67","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1107\/S1399004714021683","volume":"71","author":"A Brown","year":"2015","unstructured":"Brown, A. et al. Tools for macromolecular model building and refinement into electron cryo-microscopy reconstructions. Acta Crystallogr. D. Biol. Crystallogr. 71, 136\u2013153 (2015).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"70227_CR68","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1093\/bioinformatics\/btz564","volume":"36","author":"C Reynes","year":"2020","unstructured":"Reynes, C. et al. ISoLDE: a data-driven statistical method for the inference of allelic imbalance in datasets with reciprocal crosses. Bioinformatics 36, 504\u2013513 (2020).","journal-title":"Bioinformatics"},{"key":"70227_CR69","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1107\/S2059798318006551","volume":"74","author":"PV Afonine","year":"2018","unstructured":"Afonine, P. V. et al. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr D. Struct. Biol. 74, 531\u2013544 (2018).","journal-title":"Acta Crystallogr D. Struct. Biol."},{"key":"70227_CR70","unstructured":"Smart, O. S. et al. Grade2 1.5.0 edn (Global Phasing Ltd., 2021)."},{"key":"70227_CR71","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/pro.3786","volume":"29","author":"MG Prisant","year":"2020","unstructured":"Prisant, M. G., Williams, C. J., Chen, V. B., Richardson, J. S. & Richardson, D. C. New tools in MolProbity validation: CaBLAM for CryoEM backbone, UnDowser to rethink \u201cwaters,\u201d and NGL Viewer to recapture online 3D graphics. Protein Sci. 29, 315\u2013329 (2020).","journal-title":"Protein Sci."},{"key":"70227_CR72","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/pro.3943","volume":"30","author":"EF Pettersen","year":"2021","unstructured":"Pettersen, E. F. et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 30, 70\u201382 (2021).","journal-title":"Protein Sci."},{"key":"70227_CR73","doi-asserted-by":"publisher","first-page":"C1042","DOI":"10.1152\/ajpcell.00701.2023","volume":"326","author":"Y Nakamura","year":"2024","unstructured":"Nakamura, Y. et al. Modulation of prostaglandin transport activity of SLCO2A1 by annexin A2 and S100A10. Am. J. Physiol. Cell Physiol. 326, C1042\u2013C1053 (2024).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"70227_CR74","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1-2","author":"MJ Abraham","year":"2015","unstructured":"Abraham, M. J. et al. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1-2, 19\u201325 (2015).","journal-title":"SoftwareX"},{"key":"70227_CR75","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1002\/jcc.23702","volume":"35","author":"EL Wu","year":"2014","unstructured":"Wu, E. L. et al. CHARMM-GUI Membrane Builder toward realistic biological membrane simulations. J. Comput Chem. 35, 1997\u20132004 (2014).","journal-title":"J. Comput Chem."},{"key":"70227_CR76","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1002\/jcc.20945","volume":"29","author":"S Jo","year":"2008","unstructured":"Jo, S., Kim, T., Iyer, V. G. & Im, W. CHARMM-GUI: a web-based graphical user interface for CHARMM. J. Comput Chem. 29, 1859\u20131865 (2008).","journal-title":"J. Comput Chem."},{"key":"70227_CR77","doi-asserted-by":"crossref","unstructured":"Jorgensen, W. L., Chandrasekhar, J. & Madura, J. D. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79(1983).","DOI":"10.1063\/1.445869"},{"key":"70227_CR78","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1021\/acs.jctc.5b00935","volume":"12","author":"J Lee","year":"2016","unstructured":"Lee, J. et al. CHARMM-GUI input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM\/OpenMM simulations using the CHARMM36 additive force field. J. Chem. Theory Comput 12, 405\u2013413 (2016).","journal-title":"J. Chem. Theory Comput"},{"key":"70227_CR79","doi-asserted-by":"publisher","first-page":"7830","DOI":"10.1021\/jp101759q","volume":"114","author":"JB Klauda","year":"2010","unstructured":"Klauda, J. B. et al. Update of the CHARMM All-Atom Additive Force Field for Lipids: Validation on Six Lipid Types. J. Phys. Chem. B 114, 7830\u20137843 (2010).","journal-title":"J. Phys. Chem. B"},{"key":"70227_CR80","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1021\/ci300363c","volume":"52","author":"K Vanommeslaeghe","year":"2012","unstructured":"Vanommeslaeghe, K. & MacKerell, A. D. Jr Automation of the CHARMM General Force Field (CGenFF) I: bond perception and atom typing. J. Chem. Inf. Model 52, 3144\u20133154 (2012).","journal-title":"J. Chem. Inf. Model"},{"key":"70227_CR81","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1021\/ci3003649","volume":"52","author":"K Vanommeslaeghe","year":"2012","unstructured":"Vanommeslaeghe, K., Raman, E. P. & MacKerell, A. D. Jr Automation of the CHARMM General Force Field (CGenFF) II: assignment of bonded parameters and partial atomic charges. J. Chem. Inf. Model 52, 3155\u20133168 (2012).","journal-title":"J. Chem. Inf. Model"},{"key":"70227_CR82","doi-asserted-by":"publisher","first-page":"114107","DOI":"10.1063\/5.0020514","volume":"153","author":"M Bernetti","year":"2020","unstructured":"Bernetti, M. & Bussi, G. Pressure control using stochastic cell rescaling. J. Chem. Phys. 153, 114107 (2020).","journal-title":"J. Chem. Phys."},{"key":"70227_CR83","doi-asserted-by":"crossref","unstructured":"Bussi, G., Donadio, D. & Parrinello, M. Canonical sampling through velocity rescaling. J. Chem. Phys. 126 (2007).","DOI":"10.1063\/1.2408420"},{"key":"70227_CR84","doi-asserted-by":"publisher","first-page":"8577","DOI":"10.1063\/1.470117","volume":"103","author":"U Essmann","year":"1995","unstructured":"Essmann, U. et al. A smooth particle mesh Ewald method. J. Chem. Phys. 103, 8577\u20138593 (1995).","journal-title":"J. Chem. Phys."},{"key":"70227_CR85","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","volume":"18","author":"B Hess","year":"1997","unstructured":"Hess, B., Bekker, H., Berendsen, H. J. C. & Fraaije, J. G. E. M. LINCS: A linear constraint solver for molecular simulations. J. Comput. Chem. 18, 1463\u20131472 (1997).","journal-title":"J. Comput. Chem."},{"key":"70227_CR86","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/(SICI)1521-3773(19990115)38:1\/2<236::AID-ANIE236>3.0.CO;2-M","volume":"38","author":"X Daura","year":"1999","unstructured":"Daura, X. et al. Peptide folding: when simulation meets experiment. Angew. Chem. Int. Ed. 38, 236\u2013240 (1999).","journal-title":"Angew. Chem. Int. Ed."},{"key":"70227_CR87","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13321-021-00548-6","volume":"13","author":"C Bouysset","year":"2021","unstructured":"Bouysset, C. & Fiorucci, S. ProLIF: a library to encode molecular interactions as fingerprints. J. Cheminform 13, 72 (2021).","journal-title":"J. Cheminform"}],"updated-by":[{"DOI":"10.1038\/s41467-026-76870-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000}}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70227-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70227-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70227-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T07:02:25Z","timestamp":1787036545000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70227-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["70227"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-70227-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]},"assertion":[{"value":"7 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41467-026-76870-0","URL":"https:\/\/doi.org\/10.1038\/s41467-026-76870-0","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"2285"}}